SEARCH

SEARCH BY CITATION

References

  • Ando, M., Sugimoto, K., Kitoh, T., Sasaki, M., Mukai, K., Ando, J., Egashira, M., Schuster, S.M. & Oshimi, K. (2005) Selective apoptosis of natural killer-cell tumours by l-asparaginase. British Journal of Haematology, 130, 860868.
  • Au, W.Y., Lie, A.K.W., Liang, R., Kwong, Y.-L., Yau, C.-C., Cheung, M.M.C., Ngan, K.-C., Lau, W.-H., Wong, K.-H., Yiu, H.-Y., Cheng, H.-C., Au, K.-H. & Chan, J.K.C. (2003) Autologous stem cell transplantation for nasal NK/T-cell lymphoma: a progress report on its value. Annals of Oncology, 14, 16731676.
  • Aviles, A., Neri, N., Fernandez, R., Calva, A., Huerta-Guzman, J. & Nambo, M.J. (2003) Nasal NK/T-cell lymphoma with disseminated disease treated with aggressive combined therapy. Medical Oncology, 20, 1317.
  • Chan, J.K.C. (1997) CD56-positive putative natural killer (NK) cell lymphoma: nasal, nasal-type, blastoid, and leukaemic forms. Advances in Anatomic Pathology, 4, 163172.
  • Cheung, M.M., Chan, J.K. & Wong, K.F. (2003) Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukaemias. Seminars in Haematology, 40, 221232.
  • Cho, H.I., Hong, Y.S., Lee, M.A., Kim, E.K., Yoon, S.H., Kim, C.C. & Kim, T.G. (2006) Adoptive transfer of Epstein-Barr virus-specific cytotoxic T-lymphocytes for the treatment of angiocentric lymphomas. International Journal of Haematology, 83, 6673.
  • Choi, Y.L., Moriuchi, R., Osawa, M., Iwama, A., Makishima, H., Wada, T., Kisanuki, H., Kaneda, R., Ota, J., Koinuma, K., Ishikawa, M., Takada, S., Yamashita, Y., Oshimi, K. & Mano, H. (2005) Retroviral expression screening of oncogenes in natural killer cell leukaemia. Leukaemia Research, 29, 943949.
  • Cooper, M.A., Fehniger, T.A., Turner, S.C., Chen, K.S., Ghaheri, B.A., Ghayur, T., Carson, W.E. & Caligiuri, M.A. (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood, 97, 31463151.
  • Egashira, M., Kawamata, N., Sugimoto, K., Kaneko, T. & Oshimi, K. (1999) P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporine A and its analogue, PSC833. Blood, 93, 599606.
  • Emile, J.-F., Boulland, M.-L., Haioun, C., Kanavaros, P., Petrella, T., Delfau-Larue, M.-H., Bensussan, A., Farcet, J.-P. & Gaulard, P. (1996) CD5 CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphoma. Blood, 87, 14661473.
  • Fehniger, T.A., Cooper, M.A., Nuovo, G.J., Cella, M., Facchetti, F., Colonna, M. & Caligiuri, M.A. (2003) CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood, 101, 30523057.
  • Ferlazzo, G., Thomas, D., Lin, S.-L., Goodman, K., Morandi, B., Muller, W.A., Moretta, A. & Munz, C. (2004) The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. Journal of Immunology, 172, 14551462.
  • Fernandez, L.A., Pope, B., Lee, C. & Zayed, E. (1986) Aggressive natural killer cell leukaemia in an adult with establishment of an NK cell line. Blood, 67, 925930.
  • Freud, A.G. & Caligiuri, M.A. (2006) Human natural killer cell development. Immunological Reviews, 214, 5672.
  • Freud, A.G., Yokoyama, A., Becknell, B., Lee, M.T., Mao, H.C., Ferketich, A.K. & Caligiuri, M.A. (2006) Evidence for discrete stages of human natural killer cell differentiation in vivo. Journal of Experimental Medicine, 203, 10331043.
  • Garnache-Ottou, F., Feuillard, J. & Saas, P. (2007) Plasmacytoid dendritic cell leukaemia/lymphoma: toward a well defined entity? British Journal of Haematology, 136, 539548.
  • Harabuchi, Y., Yamanaka, N., Kataura, A., Imai, S., Kinoshita, T., Mizuno, F. & Osato, T. (1990) Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet, 335, 128130.
  • Hercend, T. & Schmidt, R.E. (1988) Characteristics and uses of natural killer cells. Immunologyl Today, 9, 291293.
  • Imamura, N., Kusunoki, Y., Kawa-Ha, K., Yumura, K., Hara, J., Oda, K., Abe, K., Dohy, H., Inada, T., Kajihara, H. & Kuramoto, A. (1990) Aggressive natural killer cell leukaemia/lymphoma: report of four cases and review of the literature. Possible existence of a new clinical entity originating from the third lineage of lymphoid cells. British Journal of Haematology, 75, 4959.
  • Imashuku, S. (2000) Advances in the management of haemophagocytic lymphohistiocytosis. International Journal of Haematology, 72, 111.
  • Isobe, Y., Sugimoto, K., Yang, L., Tamayose, K., Egashira, M., Kaneko, T., Takada, K. & Oshimi, K. (2004) Epstein-Barr virus infection of human natural-killer cell lines and peripheral blood natural killer cells. Cancer Research, 64, 21672174.
  • Isobe, K., Uno, T., Tamura, J., Kawakami, H., Ueno, N., Wakita, H., Okada, J., Itami, J. & Ito, H. (2006) Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters. Cancer, 106, 609615.
  • Jaffe, E.S. (1996) Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood, 87, 12071210.
  • Kako, S., Izutsu, K., Ohta, Y., Minatani, Y., Sugaya, M., Momose, T., Ohtomo, K., Kanda, Y., Chiba, S. & Kurokawa, M.. (2007a) FDG-PET in T-cell and NK-cell neoplasms. Annals of Oncology, in press.
  • Kako, S., Izutsu, K., Oshima, K., Sato, H., Kanda. Y., Motokura.T., Chiba, S. & Kurokawa, M.. (2007b) Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation. American Journal of Haematology, in press.
  • Kaneko, T., Fukuda, J., Yoshihara, T., Zheng, H., Mori, S., Mizoguchi, H. & Oshimi, K. (1995) Nasal natural killer (NK) cell lymphoma: report of a case with activated NK cells containing Epstein-Barr virus and expressing CD21 antigen, and comparative studies of their phenotype and cytotoxicity with normal NK cells. British Journal of Haematology, 91, 355361.
  • Karube, K., Ohshima, K., Tsuchiya, T., Yamaguchi, T., Suefuji, H., Suzumiya, J., Harada, M. & Kikuchi, M. (2003) Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification. American Journal of Surgical Pathology, 27, 13661374.
  • Kato, K., Ohshima, K., Ishihara, S., Anzai, K., Suzumiya, J. & Kikuchi, M. (1998) Elevated serum soluble Fas ligand in natural killer cell proliferative disorders. British Journal of Haematology, 103, 11641166.
  • Kawa, K. (2003) Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease. International Journal of Haematology, 78, 2431.
  • Kawa-Ha, K., Ishihara, S., Ninomiya, T., Yumura-Yagi, K., Hara, J., Murayama, F. & Hirai, K. (1989) CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. Journal of Clinical Investigation, 84, 5155.
  • Kim, H.J., Bang, S.M., Lee, J., Kwon, H.C., Suh, C., Kim, H.J., Lee, J.H., Ryoo, B.Y., Park, Y.H., Kwon, J.M., Oh, S.Y., Lee, H.R., Kim, K., Jung, C.W., Park, K. & Kim, W.S. (2006) High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases. Bone Marrow Transplantation, 37, 819824.
  • Koizumi, S., Seki, H., Tachinami, T., Taniguchi, M., Matsuda, A., Taga, K., Nakarai, T., Kato, E., Taniguchi, N. & Nakamura, H. (1986) Malignant clonal expansion of large granular lymphocytes with a Leu-11+, leu-7 surface phenotype: in vitro responsiveness of malignant cells to recombinant human interleukin 2. Blood, 68, 10651073.
  • Kwong, Y.-L. (2005) Natural killer-cell malignancies: diagnosis and treatment. Leukaemia, 19, 21862194.
  • Kwong, Y.-L., Chan, A.C. & Liang, R.H. (1997) Natural killer cell lymphoma/leukaemia: pathology and treatment. Haematology Oncology, 15, 7179.
  • Kwong, Y.-L., Yamaguchi, M., Suzuki, R., Kim, W.S., Hasegawa, Y., Izutsu, K., Suzumiya, J., Okamura, T., Nakamura, S., Kawa, K. & Oshimi, K.. (2007) Phase I study of SMILE chemotherapy for advanced or relapsed/refractory extranodal NK/T-cell lymphoma/leukaemia. Haematologica, 92(s1), 109 (Abstract 302).
  • Lanier, L.L., Chang, C., Spits, H. & Phillips, J.H. (1992) Expression of cytoplasmic CD3ε protein in activated human adult natural killer (NK) cells and CD3γ, δ, ε complexes in fetal NK cells. Implication for the relationship of NK and T lymphocytes. Journal of Immunology, 149, 18761880.
  • Lay, J.-D., Tsao, C.-J., Chen, J.-Y., Kadin, M.E. & Su, I.-J. (1997) Upregulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of haemophagocytic syndrome. Journal of Clinical Investigation, 100, 19691979.
  • Lee, J., Suh, C., Park, Y.H., Ko, Y.H., Bang, S.M., Lee, J.H., Lee, D.H., Huh, J., Oh, S.Y., Kwon, H.-C., Kim, H.J., Lee, S.I., Kim, J.H., Park, J., Oh, S.J., Kim, K., Jung, C., Park, K. & Kim, W.S. (2006a) Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study. Journal of Clinical Oncology, 24, 612618.
  • Lee, K.W., Yun, T., Kim, D.W., Im, S.A., Kim, T.Y., Yoon, S.S., Heo, D.S., Bang, Y.J., Park, S., Kim, B.K. & Kim, N.K. (2006b) First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma. Leukaemia and Lymphoma, 47, 12741282.
  • Li, Y.-X., Yao, B., Jin, J., Wang, W.-H., Liu, Y.-P., Song, Y.-W., Wang, S.-L., Liu, X.-F., Zhou, L.-Q., He, X.-H., Lu, N. & Yu, Z. (2006) Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma. Journal of Clinical Oncology, 24, 181189.
  • Liang, R., Chen, F., Lee, C.K., Kwong, Y.L., Chim, C.S., Yau, C.C. & Chiu, E. (1997) Autologous bone marrow transplantation for primary nasal T/NK cell lymphoma. Bone Marrow Transplanation, 19, 9193.
  • Lin, C.-W., Liu, T.-Y., Chen, S.-U., Wang, K.-T., Medeiros, L.J. & Hsu, S.-M. (2005) CD94 1A transcripts characterize lymphoblastic lymphoma/leukaemia of immature natural killer cell origin with distinct clinical features. Blood, 106, 35673574.
  • Liu, Y.-J. (2001) Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell, 106, 259262.
  • Liu, A., Takakuwa, T., Luo, W.J., Fujita, S. & Aozasa, K. (2006) Alterations in ATR in nasal NK/T-cell lymphoma and chronic active Epstein-Barr virus infection. Cancer Science, 97, 605610.
  • Loughran, Jr, T.P. & Starkebaum, G. (1987) Large granular lymphocyte leukaemia. Report of 38 cases and review of the literature. Medicine, 66, 397405.
  • Loughran, Jr, T.P., Hadlock, K.G., Yang, Q., Perzova, R., Zambello, R., Semenzato, G., Foung, S.K.H. & Poiesz, B.J. (1997) Seroreactivity to an envelope protein of human T-cell leukaemia/lymphoma virus in patients with CD3 (natural killer) lymphoproliferative disease of granular lymphocytes. Blood, 90, 19771981.
  • Makishima, H., Ito, T., Asano, N., Nakazawa, H., Shimodaira, S., Kamijo, Y., Nakazawa, Y., Suzuki, T., Kobayashi, H. & Ishida, F. (2005) Significance of chemokine receptor expression in aggressive NK cell leukaemia. Leukaemia, 19, 11691174.
  • Makishima, H., Ito, T., Momose, K., Nakazawa, H., Shimodaira, S., Kamijo, Y., Nakazawa, Y., Ichikawa, N., Ueno, M., Kobayashi, H., Kitano, K., Saito, H., Kiyosawa, K. & Ishida, F. (2007) Chemokine system and tissue infiltration in aggressive NK-cell leukaemia. Leukaemia Research, 31, 12451253.
  • Marquez, C., Trigueros, C., Franco, J.M., Ramiro, A.R., Carrasco, Y.R., Lopez-Botet, M. & Toribio, M.L. (1998) Identification of a common developmental pathway for thymic natural killer cells and dendritic cells. Blood, 91, 27602771.
  • Mizuno, S., Akashi, K., Ohshima, K., Iwasaki, H., Miyamoto, T., Uchida, N., Shibuya, T., Harada, M., Kikuchi, M. & Niho, Y. (1999) Interferon-γ prevents apoptosis in Epstein-Barr virus-infected natural killer cell leukaemia in an autocrine fashion. Blood, 93, 34943504.
  • Mori, K.L., Egashira, M. & Oshimi, K. (2001) Differential stage of natural killer cell-lineage lymphoproliferative disorders based on phenotypic analysis. British Journal of Haematology, 115, 225228.
  • Murashige, N., Kami, M., Kishi, Y., Kim, S.-W., Takeuchi, M., Matsue, K., Kanda, Y., Hirokawa, M., Kawabata, Y., Matsumura, T., Kusumi, E., Hirabayashi, N., Nagafuji, K., Suzuki, R., Takeuchi, K. & Oshimi, K. (2005) Allogeneic haematopoietic stem cell transplantation as a promising treatment for natural killer-cell neoplasms. British Journal of Haematology, 130, 561567.
  • Nagamine, M., Takahara, M., Kishibe, K., Nagato, T., Ishii, H., Bandoh, N., Ogino, T. & Harabuchi, Y. (2007) Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma. Virus Genes, 34, 4754.
  • Nagler, A., Lanier, L.L., Cwirla, S. & Phillips, J.H. (1989) Comparative studies of human FcRIII-positive and negative natural killer cells. Journal of Immunology, 143, 31833191.
  • Nakashima, Y., Tagawa, H., Suzuki, R., Karnan, S., Karube, K., Ohshima, K., Muta, K., Nawata, H., Morishima, Y., Nakamura, S. & Seto, M. (2005) Genome-wide array-based comparative genomic hybridization of natural killer cell lymphoma/leukaemia: different genomic alteration patterns of aggressive NK-cell leukaemia and extranodal NK/T-cell lymphoma, nasal type. Genes, Chromosomes and Cancer, 44, 247255.
  • Nash, R., McSweeney, P., Zambello, R., Semenzato, G. & Loughran, Jr, T.P. (1993) Clonal studies of CD3 lymphoproliferative disease of granular lymphocytes. Blood, 81, 23632368.
  • Nava, V.E. & Jaffe, E.S. (2005) The pathology of NK-cell lymphomas and leukaemias. Advances in Anatomic Pathology, 12, 2734.
  • Ohshima, K., Haraoka, S., Ishihara, S., Ohgami, A., Yoshioka, S., Suzumiya, J. & Kikuchi, M. (2002) Analysis of chromosome 6q deletion in EBV-associated NK cell leukaemia/lymphoma. Leukaemia and Lymphoma, 43, 293300.
  • Oshimi, K. (1988) Granular lymphocyte proliferative disorders: report of 12 cases and review of the literature. Leukaemia, 2, 617627.
  • Oshimi, K. (1996) Lymphoproliferative disorders of natural killer cells. International Journal of Haematology, 63, 279290.
  • Oshimi, K. (2000) Provisional classification and diagnostic criteria of NK-cell tumours proposed by the NK-cell Tumour Study group (in Japanese). Ketsueki-Shuyo-ka, 40, 8788.
  • Oshimi, K. (2003) Leukaemia and lymphoma of natural killer lineage cells. International Journal of Haematology, 78, 1823.
  • Oshimi, K., Yamada, Y., Kaneko, T., Nishinarita, S., Iizuka, Y., Urabe, A., Inamori, K., Asano, S., Takahashi, S., Hattori, M., Naohara, T., Ohira, Y., Togawa, A., Masuda, Y., Okubo, Y., Furusawa, S., Sakamoto, S., Omine, M., Mori, M., Tatsumi, E. & Mizoguchi, H. (1993) Laboratory findings and clinical courses of 33 patients with granular lymphocyte- proliferative disorders. Leukaemia, 7, 782788.
  • Oshimi, K., Kawa, K., Nakamura, S., Suzuki, R., Suzumiya, J., Yamaguchi, M., Kameoka, J., Tagawa, S., Imamura, N., Ohshima, K., Kojya, S., Iwatsuki, K., Tokura, Y., Sato, E. & Sugimori, H. (2005) NK-cell neoplasms in Japan. Hematology, 10, 237245.
  • Plum, J., De Smedt, M., Verhasselt, B., Offner, F., Kerre, T., Vanhecke, D., Leclercq, G. & Vandekerckhove, B. (1999) In vitro intrathymic differentiation kinetics of human fetal liver CD34+CD38- progenitors reveals a phenotypically defined dendritic/T-NK precursor split. Journal of Immunology, 162, 6068.
  • Robertson, M.J. & Ritz, J. (1990) Biology and clinical relevance of human natural killer cells. Blood, 76, 24212438.
  • Scott, A.A., Head, D.R., Kopecky, K.J., Appelbaum, F.R., Theil, K.S., Grever, M.R., Chen, I.-M., Whittaker, M.H., Griffith, B.B., Licht, J.D., Waxman, S., Whalen, M.M., Bankhurst, A.D., Richter, L.C., Grogan, T.M. & Willman, C.L. (1994) HLA-DR, CD33+, CD56+, CD16 myeloid/natural killer cell acute leukaemia: a previously unrecognized form of acute leukaemia potentially misdiagnosed as French-American-British acute myeloid leukaemia-M3. Blood, 84, 244255.
  • Semenzato, G., Pandolfi, F., Chisesi, T., De Rossi, G., Pizzolo, G., Zambello, R., Trentin, L., Agostini, C., Dini, E., Vespinani, M., Cafaro, A., Pasqualetti, D., Giubellino, M.C., Migone, N. & Foa, R. (1987) The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer, 60, 29712978.
  • Siu, L.L.P., Wong, K.F., Chan, J.K. & Kwong, Y.L. (1999) Comparative genomic hybridization analysis of natural killer cell lymphoma/leukaemia: recognition of consistent patterns of genetic alterations. American Journal of Pathology, 155, 14191425.
  • Siu, L.L.P., Chan, V., Chan, J.K.C., Wong, K.F., Liang, R. & Kwong, Y.L. (2000) Consistent patterns of allelic loss in natural killer cell lymphoma. American Journal of Pathology, 157, 18031809.
  • Siu, L.L.P., Chan, J.K.C. & Kwong, Y.L. (2002) Natural killer cell malignancies: clinicopathological and molecular features. Histology and Histopathology, 17, 539554.
  • Soler, J., Bordes, R., Ortuno, F., Montagud, M., Martorell, J., Pons, C., Nomdedeu, J., Lopez-Lopez, J.J., Prat, J. & Rutllant, M. (1994) Aggressive natural killer cell leukaemia/lymphoma in two patients with lethal midline granuloma. British Journal of Haematology, 86, 659662.
  • Song, S.-Y., Kim, W.S., Ko, Y.-H., Kim, K., Lee, M.H. & Park, K. (2002) Aggressive natural killer cell leukaemia: clinical features and treatment outcome. Haematologica, 87, 13431345.
  • Spits, H. & Lanier, L.L. (2007) Natural killer or dendritic: what’s in a name? Immunity, 26, 1116.
  • Spits, H., Blom, B., Jaleco, A.-C., Weijer, K., Verschuren, M.C.M., Van Dongen, J.J.M., Heemskerk, M.H.M. & Res, P.C.M. (1998) Early stages in the development of human T, natural killer and thymic dendritic cells. Immunological Reviews, 165, 7586.
  • Sugimoto, K.J., Kawamata, N., Sakajiri, S. & Oshimi, K. (2002) Molecular analysis of oncogenes, ras family genes (N-ras, K-ras, H-ras), myc family genes (c-myc, N-myc) and mdm2 in natural killer cell neoplasms. Japanese Journal of Cancer Research, 93, 12701277.
  • Suzuki, R. (2005) Leukaemia and lymphoma of natural killer cells. Journal of Clinical and Experimental Haematopathology, 45, 5170.
  • Suzuki, R. & Nakamura, S. (1999) Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukaemia and blastic NK cell lymphoma/leukaemia. Leukaemia Research, 23, 615624.
  • Suzuki, R., Yamamoto, K., Seto, M., Kagami, Y., Ogura, M., Yatabe, Y., Suchi, T., Kodera, Y., Morishima, Y., Takahashi, T., Saito, H., Ueda, R. & Nakamura, S. (1997) CD7+ and CD56+ myeloid/natural killer cell precursor acute leukaemia: a distinct haematolymphoid disease entity. Blood, 90, 24172428.
  • Suzuki, R., Murata, M., Kami, M., Ohtake, S., Asou, N., Kodera, Y., Tomonaga, M., Masaki, Y., Kusumoto, S., Takeuchi, J., Matsuda, S., Hirai, H., Yorimitsu, S., Hamajima, N., Seto, M., Shimoyama, M., Ohno, R., Morishima, Y. & Nakamura, S. (2003) Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukaemai M0. International Journal of Haematology, 77, 482489.
  • Suzuki, R., Suzumiya, J., Nakamura, S., Aoki, S., Notoya, A., Ozaki, S., Gondo, H., Hino, N., Mori, H., Sugimori, H., Kawa, K. & Oshimi, K. (2004) Aggressive natural killer-cell leukaemia revisited: large granular lymphocyte leukaemia of cytotoxic NK cells. Leukaemia, 18, 763770.
  • Suzuki, R., Nakamura, S., Suzumiya, J., Ichimura, K., Ogata, K., Kura, Y., Aikawa, K., Teshima, H., Sako, M., Kojima, H., Nishio, M., Yoshino, T., Sugimori, H., Kawa, K. & Oshimi, K. (2005) Blastic natural killer cell lymphoma/leukaemia (CD56-positive blastic tumour). Prognostication and categorization according to anatomic sites of involvement. Cancer, 104, 10221031.
  • Suzuki, R., Suzumiya, J., Nakamura, S., Kagami, Y., Kameoka, J.-I., Sakai, C., Mukai, H., Takenaka, K., Yoshino, T., Tsuzuki, T., Sugimori, H., Kawa, K., Kodera, Y. & Oshimi, K. (2006) Haematopoietic stem cell transplantation for natural killer-cell lineage neoplasms. Bone Marrow Transplantation, 37, 425431.
  • Suzumiya, J., Takeshita, M., Kimura, N., Kikuchi, M., Uchida, T., Hisano, Y., Eura, Y., Kozuru, M., Nomura, Y., Tomita, K., Komiyama, S. & Okumura, M. (1994) Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood, 83, 22552260.
  • Suzumiya, J., Ohshima, K., Takeshita, M., Kanda, M., Kawasaki, C., Kimura, N., Tamura, K. & Kikuchi, M. (1999) Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene. Leukaemia and Lymphoma, 35, 567578.
  • Takahashi, N., Miura, I., Chubachi, A., Miura, A.B. & Nakamura, S. (2001) A clinicopathological study of 20 patients with T/natural killer (NK)-cell lymphoma-associated haemophagocytic syndrome with specific reference to nasal and nasal-type NK/T-cell lymphoma. International Journal of Haematology, 74, 303308.
  • Tani, R., Ozaki, S., Kosaka, M., Fujiwara, S., Shibata, H., Wakatsuki, S. & Matsumoto, T. (1999) Fas ligand-induced apoptosis of hepatocytes in natural killer cell leukaemia. British Journal of Haematology, 106, 709712.
  • Tefferi, A., Li, C.Y., Witzig, T.E., Dhodapkar, M.V., Okuno, S.H. & Phyliky, R.L. (1994) Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood, 84, 27212725.
  • Teruya-Feldstein, J., Jaffe, E.S., Burd, P.R., Kanegane, H., Kingma, D.W., Wilson, W.H., Longo, D.L. & Tosato, G. (1997) The role of Mig, monokine induced by interferon-γ, and IP-10, the interferon-γ-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood, 90, 40994105.
  • Tien, H.-F., Su, I.-J., Tang, J.-L., Lee, F.-Y., Chen, Y.-C. & Chuang, S.-M. (1997) Clonal chromosomal abnormalities as direct evidence for clonality in nasal T/natural killer cell lymphomas. British Journal of Haematology, 97, 621625.
  • Trinchieri, G. (1989) Biology of natural killer cells. Advances in Immunology, 47, 187376.
  • Uno, M., Tsuchiyama, J., Moriwaki, A., Noguchi, T., Mizoguchi, K., Ogino, T., Yoshino, T., Okada, S. & Harada, M. (2001) In vitro induction of apoptosis for nasal angiocentric natural killer cell lymphoma-derived cell line, NK-YS, by etoposide and cyclosporine A. British Journal of Haematology, 113, 10091014.
  • Wong, K.F., Chan, J.K.C. & Kwong, Y.L. (1997) Identification of del(6)(q21q25) as a recurring chromosomal abnormality in putative NK cell lymphoma/leukaemia. British Journal of Haematology, 98, 922926.
  • Xu, J.-X., Hoshida, Y., Yang, W.-I., Inohara, H., Kubo, T., Kim, G.-E., Yoon, J.-H., Kojya, S., Bandoh, N., Harabuchi, Y., Tsutsumi, K., Xu, I., Jia, X.-S., Kirihata, M., Tsukuma, H. & Aozasa, K. (2006) Life-style and environmental factors in the development of nasal NK/T-cell lymphoma: a case-control study in East Asia. International Journal of Cancer, 120, 406410.
  • Yamaguchi, M., Kita, K., Miwa, H., Nishii, K., Oka, K., Ohno, T., Shirakawa, S. & Fukumoto, M. (1995) Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells. Cancer, 76, 23512356.
  • Yamaguchi, M., Ogawa, S., Nomoto, Y., Oka, K., Taniguchi, M., Nakase, K., Kobayashi, T. & Shiku, H. (2001) Treatment outcome of nasal NK-cell lymphoma: a report of 12 consecutively-diagnosed cases and a review of the literature. Journal of Clinical and Experimental Haematopathology, 41, 9399.
  • Yamaguchi, M., Oguchi, M., Tobinai, K., Maseki, N., Suzuki, T., Masaki, Y., Nakata, M., Hata, H., Usui, N., Wasada, I., Nakamura, S., Hotta, H. & Oshimi, K.. (2005) Phase I/II study of concurrent chemoradiotherapy for newly-diagnosed, localized nasal NK/T-cell lymphoma: results of a phase I portion of JCOG0211-DI. Blood, 106, Abstract 2685.
  • Yamamoto, T., Iwasaki, T., Watanabe, N., Oshimi, K., Naito, M., Tsuruo, T. & Kobayashi, Y. (1993) Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders. Blood, 81, 13421346.
  • Ye, Y., Li, T., Zhang, B. & Guo, Z. (2007) Amplification and specific expression of T-bet gene in nasal NK/T-cell lymphoma. Leukaemia and Lymphoma, 48, 168173.
  • Yong, W., Zheng, W., Zhang, Y., Zhu, J., Wei, Y., Zhu, D. & Li, J. (2003) l-Asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma. International Journal of Haematology, 78, 163167.
  • Zambello, R., Trentin, L., Ciccone, E., Bulian, P., Agostini, C., Moretta, A., Moretta, L. & Semenzato, G. (1993) Phenotypic diversity of natural killer (NK) populations in patients with NK-type lymphoproliferative disease of granular lymphocytes. Blood, 81, 23812385.
  • Zambello, R., Loughran, Jr, T.P., Trentin, L., Pontisso, P., Battistella, L., Raimondi, R., Facco, M., Sancetta, R., Agostini, C., Pizzolo, G. & Semenzato, G. (1995) Serologic and molecular evidence for a possible pathogenetic role of viral infection in CD3-negative natural killer-type lymphoproliferative disease of granular lymphocytes. Leukaemia, 9, 12071211.